China, Oct. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Ultrasound-Guided Microwave Ablation Versus Radioiodine Therapy for Refractory or Recurrent Graves’ Disease: A Comparative Study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135479
Registration Time: 2026/10/30
Type: Observational study
Primary Sponsor: The first affiliated hostipal of nanchang university
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=349962
Published by HT Digital Content Services with permission from Health Daily Digest....